Affinity Asset Advisors, LLC Lantheus Holdings, Inc. Transaction History

Affinity Asset Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$60.27 - $90.75 $1.81 Million - $2.72 Million	30,000 New	30,000 $2.08 Million
Q1 2023 May 15, 2023	SELL	$47.76 - $82.86 $1.45 Million - $2.52 Million	-30,386 Reduced 50.12%	30,244 $2.5 Million
Q4 2022 Feb 13, 2023	SELL	$48.76 - $77.67 $3.38 Million - $5.39 Million	-69,370 Reduced 53.36%	60,630 $3.09 Million
Q3 2022 Nov 14, 2022	SELL	$61.42 - $86.29 $614,200 - $862,900	-10,000 Reduced 7.14%	130,000 $9.14 Million
Q2 2022 Aug 12, 2022	BUY	$55.54 - $72.65 $1.39 Million - $1.82 Million	25,000 Added 21.74%	140,000 $9.24 Million
Q1 2022 May 13, 2022	BUY	$24.28 - $56.64 $2.79 Million - $6.51 Million	115,000 New	115,000 $6.36 Million

540

68M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.14B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Affinity Asset Advisors, LLC with notifications on news.